Eli Lilly says next-generation weight loss drug clears crucial obesity trial
By CNBC | 1 min read
The results bring Lilly one step closer to filing for approval of the injection, retatrutide, which works differently from existing injections and pills.
# Eli Lilly says next-generation weight loss drug clears crucial obesity trial The results bring Lilly one step closer to filing for approval of the injection, retatrutide, which works differently from existing injections and pills. **Read the full article:** [CNBC](https://www.cnbc.com/2026/05/21/eli-lilly-weight-loss-drug-retatrutide-clears-obesity-trial.html) *This article was originally published by CNBC. MoneyWiseInc provides expert curation of the best financial content from trusted sources.*